BioSpace News Archive

Perspectum Announces American Medical Association (AMA) Issues Two Unique Category III CPT ® Codes Priced Appropriately by the Centers for Medicare & Medicaid Services (CMS) for Noninvasive Biliary Anatomy Assessment With MRCP+.

Edward Hu to Replace Xiao Le as Non-Executive Director.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced new robust, real-world evidence confirming AVISE® testing enables decisive clinical action in the differential diagnosis for lupus.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global Parkinson’s disease therapeutics market was valued at US$ 2.18 Bn in 2016 and is projected to register a cumulative annual growth rate of more than 10.9% from 2017 to 2025, according to a new report.

POXEL SA announces the publication of two preclinical articles on X-Linked Adrenoleukodystrophy for PXL065 and PXL770.

Mainz Biomed N.V. is pleased to host a webcast on July 12, 2022 at 4:00pm ET to provide an update on the Company’s progress for the first half of 2022, and to outline the plan for the balance of the fiscal year.

AlzeCure Pharma AB announced that an abstract on clinical study data with its leading drug candidate NeuroRestore ACD856, which is being developed with a focus on Alzheimer’s disease, has been accepted for a poster presentation at AAIC 2022, which this year will be held in San Diego, USA, from July 31 to August 4.

CEPI, the Coalition for Epidemic Preparedness Innovations, and Codiak BioSciences announced the latest funding award under CEPI’s US $200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2 and other Betacoronaviruses.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a partnership today with TeamSmile.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Tuesday, August 2, 2022 at 8:30 a.m. ET.